Manufacturers: Corepharma llc, Impax laboratories inc +5 more
Benzphetamine is a sympathomimetic used to manage exogenous obesity short term.
Benzphetamine is a sympathomimetic used to manage exogenous obesity short term.
The mechanism of action of these drugs is not fully understood, however it may be similar to that of amphetamines. Amphetamines stimulate noepinephrine and dopamine release in nerve endings in the lateral hypothalamic feeding centre, decreasing appetite. This release is mediated by the binding of benzphetamine to centrally located adrenergic receptors.
For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction
1 associated conditions
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
